Badly designed studies may lead to the efficacy of drugs being overestimated and money being wasted on trials that prove fruitless, according to a new study from McGill University in Canada.
Category:
Published on: 14 Oct 2015
Only 11% of drugs that enter clinical trials in humans are ultimately found safe and effective enough to receive regulatory approval.
Category:
Published on: 24 Jul 2013
